Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Enrolling by invitation · NCT02579044 · Registry updated 2026-04-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, hereditary disease, inborn errors of metabolism, laminopathy, metabolic disease, progeroid syndrome | Enrolling by invitation | Phase 1 / Phase 2 | 2026-04-02 | NCT02579044 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boston Children's Hospital | 238 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |